|
Do you suffer from GOUT ATTACKS?
If you have gout, you may be eligible to participate in the RE-SURGE
study, evaluating an investigational medicine for preventing acute
gout flares in select patients. Researchers are interested in determining
the effectiveness and safety of the investigational medicine when
used in combination with commonly used FDA-approved medicines for
gout treatment.
To be considered for participation in the RE-SURGE study, you must:
- Be 18-80 years of age,
- Have a history of gout and are at risk of gout flare,
- Be able to or are already receiving treatment with allopurinol, AND
- Not currently be experiencing a gout flare.
The investigator will work with you to determine whether you qualify
for the study, using a more comprehensive list of criteria. Qualified
participants will receive study medicine as well as study-related
medical evaluations at no cost. Reimbursement for time and travel
may also be available.
To learn more, please contact:
Novara Clinical Research
(480) 924-0425
Your senior years should be spent having fun…not on the run.
As we age, OAB symptoms such as sudden urges to urinate and frequent
wetting episodes become more common.
If you are frustrated living with OAB, you may be interested in
a research study we are conducting to evaluate an approved medication
for overactive bladder.
If you take part in this research study, you will attend five office
visits over a 14-week period. If qualified, you will receive the
study medication or placebo (an inactive look-alike pill) and study-related
care at no cost. You may also be compensated for time and travel.
We are looking for male and female participants who:
- Are age 65 or older
- Have experienced overactive bladder symptoms for at least 3 months
- Have strong, sudden urges to urinate
- Experience frequent wetting episodes
- Have health problems related to aging
Novara Clinical Research is currently conducting a clinical research study of
a study drug or placebo for otitis externa (swimmer's ear).
Qualified participants will receive study medication or placebo and medical exams
at no cost.
Compensation is available for time and travel.
For more information, please call:
Novara Clinical Research
480-924-0425
We are enrolling adult volunteers now
If you have type 2 diabetes, find out if you qualify for a clinical research study
of an investigational oral diabetes medication.
You may be eligible if:
- You have a confirmed diagnosis of type 2 diabetes, AND
- You are age 30 or older and have had a heart attack or stroke, or other vascular
problem
OR
- You are 50 or older and have been told by your doctor that you are at high
risk for heart disease
If eligible to participate, you will be seen by a study doctor and receive study-related
testing and study medication at no cost. Once enrolled, you may be reimbursed for
parking and travel expenses.
For more information, please contact:
Novara Clinical Research
(480) 924-0425
Novara Clinical Research is looking for pediatric subjects to participate in a
clinical research study of an investigational drug, MK-0462 (rizatriptan) compared
to placebo (an inactive substance) in pediatric subjects ages 6-17 with migraines.
This study lasts approximately 4 months and has 2 office visits. Study-related
drugs (may include placebo), lab work, and study-related physical exams are provided
to participants in this study at no cost. Compensation is available to qualified
participants for each completed visit for time and travel.
Your child may be eligible for this study if:
- Your child has had at least one, but not more than 8 moderate or severe migraine
attacks per month for the past 2 months
- Your child cannot have experienced satisfactory relief of their migraine pain
through acetaminophen or any NSAIDs (e.g. ibuprofen, aleve)
- Parent or guardian must accompany child to first appointment
If you are interested in finding out more about this study, please call us at
(480)924-0425. One of our staff will be happy to give you further information
regarding this study and will schedule you an appointment so you may review the
study in more detail with one of our study physicians. If you know of anyone
that might be interested in this study, please feel free to pass this information
along to them.
Novara Clinical Research is looking for pediatric subjects to participate in a
clinical research study of an investigational drug, MK-0462 (rizatriptan), treatment
for up to 12 months for acute migraines in individuals 12-17 years of age.
This study lasts approximately 12 months and has 8 office visits. Study-related
drugs (may include placebo), lab work, and study-related physical exams are provided
to participants in this study at no cost. Compensation is available to qualified
participants for each completed visit for time and travel.
Your child may be eligible for this study if:
- Your child has had at least 1 but not more than 8 moderate or severe migraine
attacks per month for the past 2 months
- Your child cannot have experienced satisfactory relief of their migraine pain
through acetaminophen or any NSAIDs (e.g. ibuprofen, aleve)
- Parent or guardian is able to accompany child to first appointment
If you are interested in finding out more about this study, please call us at
(480)924-0425. One of our staff will be happy to give you further information
regarding this study and will schedule you an appointment so you may review the
study in more detail with one of our study physicians. If you know of anyone
that might be interested in this study, please feel free to pass this information
along to them.
Novara Clinical Research is looking for subjects to participate in a clinical
research study of an investigational drug vs. placebo (an inactive substance) for
people with chronic constipation.
This study lasts approximately 4 weeks and has approximately 6 office visits. Study-related
drugs (may include placebo), lab work, and study-related physical exams are provided
to participants in this study at no cost. Compensation is available to qualified
participants for each completed visit for time and travel.
Subjects interested in this study should:
- Be between 18 and 75 years of age
- Have had symptoms constipation for at least 3 months
- Have fewer than 3 BM's per week
- Not have been diagnosed or treated for cancer in the last 5 years (treated
basal or squamous cell skin cancer is ok)
If you are interested in finding out more about this study, please call us at
(480)924-0425. One of our staff will be happy to give you further information
regarding this study and will schedule you an appointment so you may review the
study in more detail with one of our study physicians. If you know of anyone
that might be interested in this study, please feel free to pass this information
along to them. |